High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.

SCID mouse tibialis anterior muscles were first irradiated to prevent regeneration by host myoblasts and injected with notexin to damage the muscle fibers and trigger regeneration. The muscles were then injected with roughly 5 million human myoblasts. 1 mo later, 16-33% of the normal number of muscle fibers were present in the injected muscle, because of incomplete regeneration. However, > 90% of these muscle fibers contained human dystrophin. Some newly formed muscle fibers had an accumulation of human dystrophin and desmin on a part of their membrane. Such accumulations have been demonstrated at neuromuscular junctions before suggesting that the new muscle fibers are innervated and functional. The same pool of clones of human myoblasts produced only < or = 4% of muscle fibers containing human dystrophin when injected in nude mice muscles. Several of the human myoblasts did not fuse and remained in interstitial space or tightly associated with muscle fibers suggesting that some of them have formed satellite cells. Moreover, cultures of 98% pure human myoblasts were obtained from transplanted SCID muscles. In some mice where the muscle regeneration was not complete, the muscle fibers containing human dystrophin also expressed uniformly HLA class 1, confirming that the fibers are of human origin. The presence of hybrid muscle fibers containing human dystrophin and mouse MHC was also demonstrated following transplantation. These results establish that in absence of an immune reaction, transplanted human myoblasts participate to the muscle regeneration with a high degree of efficacy even if the animals were killed only 1 mo after the transplantation.

[1]  J. Huard,et al.  Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection , 1994, Muscle & nerve.

[2]  J. Huard,et al.  Utilization of an Antibody Specific for Human Dystrophin to Follow Myoblast Transplantation in Nude Mice , 1993, Cell transplantation.

[3]  C. Richards,et al.  Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.

[4]  E. Hoffman Myoblast Transplantation: What's Going on? , 1993 .

[5]  J. Bouchard,et al.  Human myoblast transplantation: Preliminary results of 4 cases , 1992, Muscle & nerve.

[6]  H. Blau,et al.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation , 1992, Nature.

[7]  A. Irintchev,et al.  Formation of new muscle fibres and tumours after injection of cultured myogenic cells , 1991, Journal of neurocytology.

[8]  D. Bentley,et al.  Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. , 1991, American journal of human genetics.

[9]  T. Partridge Invited review: Myoblast transfer: A possible therapy for inherited myopathies? , 1991, Muscle & nerve.

[10]  J. Huard,et al.  Is dystrophin present in the nerve terminal nat the neuromuscular junction? An immunoshistochemical study of the heterozygote dystrophic (mdx) mouse , 1991, Synapse.

[11]  H. Jockusch,et al.  Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.

[12]  E. Hoffman,et al.  Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse , 1990, The Journal of cell biology.

[13]  Simon C Watkins,et al.  Somatic reversion/suppression of the mouse mdx phenotype in vivo , 1990, Journal of the Neurological Sciences.

[14]  Y. Sunada,et al.  Dense immunostainings on both neuromuscular and myotendon junctions with an anti-dystrophin monoclonal anfibody , 1989 .

[15]  Y. Pouliot,et al.  Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. , 1989, The American journal of pathology.

[16]  S. Dimauro,et al.  Cell fractionation studies indicate that dystrophin is a protein of surface membranes of skeletal muscle. , 1989, The Biochemical journal.

[17]  A. Engel,et al.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. , 1989, Human pathology.

[18]  L. Kunkel,et al.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.

[19]  D. Watt,et al.  Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells , 1988, Journal of the Neurological Sciences.

[20]  S. Dimauro,et al.  Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.

[21]  L. Kunkel,et al.  Cell and fiber type distribution of dystrophin , 1988, Neuron.

[22]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[23]  Simon C Watkins,et al.  Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.

[24]  R. Hodges,et al.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle , 1988, Nature.

[25]  L. Kunkel,et al.  Subcellular fractionation of dystrophin to the triads of skeletal muscle , 1987, Nature.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[28]  J. Harris,et al.  FURTHER OBSERVATIONS ON THE PATHOLOGICAL RESPONSES OF RAT SKELETAL MUSCLE TO TOXINS ISOLATED FROM THE VENOM OF THE AUSTRALIAN TIGER SNAKE, NOTECHIS SCUTATUS SCUTATUS , 1978, Clinical and experimental pharmacology & physiology.

[29]  P. Law,et al.  Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. , 1992, Cell transplantation.

[30]  J. Morgan Practical aspects of myoblast implantation: investigations on two inherited myopathies in animals. , 1990, Advances in experimental medicine and biology.

[31]  K. Beam Duchenne muscular dystrophy. Localizing the gene product. , 1988, Nature.

[32]  T. Tsukahara,et al.  Negative immunostaining of Duchenne muscular dystrophy(DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. , 1988 .

[33]  S. Dimauro,et al.  RAPID COMMUNICATION Immunocytochemical Study of Dystrophin in Muscle Culturesfrom Patients with Duchenne Muscular Dystrophy and Unaffected Control Patients , 2022 .

[34]  P. Law,et al.  Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. , 1988, Transplantation proceedings.

[35]  M. W. Thompson,et al.  Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy , 1985, Nature.

[36]  J. C. Vuletin,et al.  A Light and Electron Microscopic Study , 1976 .